Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3- and 6-month time points.
about
Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3- and 6-month time points.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Achieving early molecular resp ...... he 3- and 6-month time points.
@en
type
label
Achieving early molecular resp ...... he 3- and 6-month time points.
@en
prefLabel
Achieving early molecular resp ...... he 3- and 6-month time points.
@en
P2093
P2860
P356
P1476
Achieving early molecular resp ...... the 3- and 6-month time points
@en
P2093
Bipin N Savani
Mohamad Mohty
Simona Lapusan
P2860
P304
P356
10.1111/EJH.12453
P50
P577
2014-10-27T00:00:00Z